Survival Impact of Locoregional Treatment of the Primary Tumor in De Novo Metastatic Breast Cancers in a Large Multicentric Cohort Study: A Propensity Score-Matched Analysis

Elvire Pons-Tostivint,Youlia M. Kirova,A. Lusque,Mario Campone,Julien Geffrelot,Chafika Mazouni,Audrey Mailliez,David Pasquier,N. Madranges,Nelly Firmin,Agathe Crouzet,Anthony Gonçalves,Clémentine Jankowski,Thibault De La Motte Rouge,Nicolas Pouget,Brigitte de la Lande,Delphine Mouttet-Boizat,Jean-Marc Ferrero,L. Uwer,Jean-Christophe Eymard,Marie-Ange Mouret-Reynier,T. Petit,Mathieu Robain,Thomas Filleron,Christian Cailliot,Florence Dalenc

Survival Impact of Locoregional Treatment of the Primary Tumor in De Novo Metastatic Breast Cancers in a Large Multicentric Cohort Study: A Propensity Score-Matched Analysis

2019

Introduction Improvement in overall survival (OS) by locoregional treatment (LRT) of the primary tumor in de novo metastatic breast cancer (MBC) patients remains controversial.

Keywords:

Pathology
Oncology
Primary tumor
Propensity score matching
Cohort study
Metastatic breast cancer
Medicine
Internal medicine
metastatic breast
General surgery
Surgical oncology
overall survival

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations